The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
GCLLSG 2016 | How does an understanding of the microenvironment aid research in CLL?
Paolo Ghia, MD, PhD of Università Vita-Salute San Raffaele, Milan, Italy talks about how understanding the microenvironment of chronic lymphocytic leukemia (CLL) cells can open potential for future research. CLL is very heterogeneous; some patients can share a common immunoglobulin, therefore also sharing clinical outcome. There is a common functionality of the B-cell receptor, which can open large potential in future research, in both translational terms and clinical terms. It can also perhaps be used for diagnostic purposes. Recorded at the 2016 International Workshop of the German CLL Study Group (GCLLSG) in Cologne, Germany.
